These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 23840605)
1. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines. Lee SL; Chou CC; Chuang HC; Hsu EC; Chiu PC; Kulp SK; Byrd JC; Chen CS PLoS One; 2013; 8(6):e67149. PubMed ID: 23840605 [TBL] [Abstract][Full Text] [Related]
2. Receptor-specific mechanisms regulate phosphorylation of AKT at Ser473: role of RICTOR in β1 integrin-mediated cell survival. Riaz A; Zeller KS; Johansson S PLoS One; 2012; 7(2):e32081. PubMed ID: 22384145 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W. Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186 [TBL] [Abstract][Full Text] [Related]
4. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. McDonald PC; Oloumi A; Mills J; Dobreva I; Maidan M; Gray V; Wederell ED; Bally MB; Foster LJ; Dedhar S Cancer Res; 2008 Mar; 68(6):1618-24. PubMed ID: 18339839 [TBL] [Abstract][Full Text] [Related]
5. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK; Pizzo SV PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Akt (ser473) phosphorylation and rapamycin-resistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor-1-targeting vector. Koide H; Asai T; Furuya K; Tsuzuku T; Kato H; Dewa T; Nango M; Maeda N; Oku N Biol Pharm Bull; 2011; 34(5):602-8. PubMed ID: 21532145 [TBL] [Abstract][Full Text] [Related]
7. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. Hresko RC; Mueckler M J Biol Chem; 2005 Dec; 280(49):40406-16. PubMed ID: 16221682 [TBL] [Abstract][Full Text] [Related]
8. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254 [TBL] [Abstract][Full Text] [Related]
9. Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2. Soares HP; Ming M; Mellon M; Young SH; Han L; Sinnet-Smith J; Rozengurt E Mol Cancer Ther; 2015 Apr; 14(4):1014-23. PubMed ID: 25673820 [TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide-dependent kinase 1 and mTORC2 synergistically maintain postnatal heart growth and heart function in mice. Zhao X; Lu S; Nie J; Hu X; Luo W; Wu X; Liu H; Feng Q; Chang Z; Liu Y; Cao Y; Sun H; Li X; Hu Y; Yang Z Mol Cell Biol; 2014 Jun; 34(11):1966-75. PubMed ID: 24662050 [TBL] [Abstract][Full Text] [Related]
11. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906 [TBL] [Abstract][Full Text] [Related]
12. Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells. Tandon M; Chen Z; Pratap J Breast Cancer Res; 2014 Jan; 16(1):R16. PubMed ID: 24479521 [TBL] [Abstract][Full Text] [Related]
13. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis. Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Sarbassov DD; Guertin DA; Ali SM; Sabatini DM Science; 2005 Feb; 307(5712):1098-101. PubMed ID: 15718470 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex. Misra UK; Pizzo SV J Cell Biochem; 2012 May; 113(5):1488-500. PubMed ID: 22173835 [TBL] [Abstract][Full Text] [Related]
16. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT). Serrano I; McDonald PC; Lock FE; Dedhar S Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280 [TBL] [Abstract][Full Text] [Related]
17. Identification of rictor as a novel substrate of Polo-like kinase 1. Shao T; Liu X Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006 [TBL] [Abstract][Full Text] [Related]
18. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition. Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Persad S; Attwell S; Gray V; Delcommenne M; Troussard A; Sanghera J; Dedhar S Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3207-12. PubMed ID: 10716737 [TBL] [Abstract][Full Text] [Related]
20. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]